Liberation of Pser68-Plm Inhibition of NCX1 by an Optimized Anchoring Disruptor Peptide  by Hodne, Kjetil et al.
434a Tuesday, February 10, 2015electrophysiology in cultured rat striatal neurons and transfected HEK 293
cells. We determined that 79 53% of cultured cells endogenously expressed
b3, and 94% of neurons gave tonic-level GABA-evoked currents blocked by
phasic concentrations of dopamine (0.1-10 mM). Inhibition was recapitulated
in HEK 293 cells transfected with a1b3, a1b3d or a1b2g2 subunits, but we
instead observed potentiation in a1b3g2 and a5b3g2. Surprisingly, dopamine
(1 mM) evoked rapid currents in a1b2g2, a1b3g2 and a5b3g2 in the absence
of GABA. In a1b3(H267A)g2 (a1Zb3g2) receptors insensitive to trace Zn2þ
inhibition, we found that other biogenic amines evoked comparatively smaller
currents than DA. When the ratio of a1 was increased or we mutated a critical
Zb3 tyrosine residue (Y62L), relative dopamine responses decreased. Further-
more, dopamine activity was retained but GABA activity was drastically
reduced in Zb3g2 receptors, while Zb3 or g2 alone did not elicit currents.
Finally, dopamine currents were picrotoxin- but not bicuculline- or gabazine-
sensitive. Taken together, dopamine at phasic levels is a GABAA allosteric
modulator that may inhibit tonic GABA in prototypical a-containing GABAA
receptors. However, at b/g-containing receptors that do not need a subunits,
dopamine acts as a positive allosteric modulator.
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GABA(A) receptors shape synaptic transmission by modulating Cl- conduc-
tance across the cell membrane. Remarkably, animal toxins that target
GABA(A) receptors have not yet been identified. Here, we report the discovery
of MmTX1 and MmTX2, two toxins present in Costa Rican coral snake venom
that bind to GABA(A) receptors at nanomolar concentrations. Studies with
recombinant and synthetic toxin variants on hippocampal neurons and
cells expressing common receptor compositions suggest that MmTX1 and
MmTX2 potentiate GABA(A) receptor opening and accelerate desensitization
when an agonist is present. In concert, hippocampal neuron excitability
measurements reveal a toxin-induced transitory network inhibition followed
by an increase in spontaneous activity. Moreover, toxin injections into mouse
brain result in reduced basal activity between intense seizures. Altogether, we
characterized the first animal toxins that potently modulate GABA(A) receptor
function, thereby establishing a novel class of tools to study this receptor
family.
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GABA-A receptors (GABAARs) are the target for many therapeutic drugs
including benzodiazepines (BZDs), barbiturates, anesthetics and neurosteroids.
These drugs bind to distinct sites and potentiate GABA-induced currents. They
are often used in combination but little is known about mechanism(s) under-
lying their interactions. Recent crystal structures of GLIC and the glutamate-
activated chloride channel suggest agonist-mediated channel opening is
associated with expansion of transmembrane interfaces between M3 and M1
helices of adjacent subunits. Here, we examined if binding of different allo-
steric drugs and combinations of these drugs to a1b2g2L GABAARs induce
similar motions. We also tested whether potentiation of GABA-mediated cur-
rent by pairs of drugs binding to distinct sites are additive or super-additive.
We individually inserted a cysteine in the M1 helices of each GABAAR subunit
at a1I227, b2L223 and g2LI238 to monitor motions at different intersubunit in-
terfaces. We expressed wild-type and mutant GABAARs in Xenopus oocytes.
We measured rates of modification of the substituted cysteines in the absence
and presence of different combinations of allosteric modulators that bind to
different sites: the intravenous anesthetics pentobarbital (PB) and etomidate,
the neurosteroid THDOC and the benzodiazepine flurazepam. When applied
alone, flurazepam and THDOC induced distinct motions in the intersubunit in-
terfaces, flurazepam increased rate of modification of only gI238C whereas
THDOC only increased the rate of bL223C. When flurazepam and THDOC
were co-applied, no change in rate of modification of gI238C was observed
indicating that the presence of THDOC inhibited the ability of flurazepam toelicit structural rearrangements near gI238C. The data suggest structural mech-
anisms underlying the effects of combining drugs are different than mecha-
nisms underlying their actions alone.
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The cardiac sodium-calcium exchanger (NCX1) is an important regulator of
intracellular Ca2þ ([Ca2þ]i) and a potential therapeutic target in heart failure.
Among potential interacting partners regulating NCX1 activity is the trans-
membrane protein phospholemman (PLM); a substrate for protein kinase A
and protein kinase C. Several reports have demonstrated that binding of phos-
phorylated PLM (pSer68-PLM) to NCX1 leads to NCX1 inhibition, while other
studies have failed to demonstrate a functional interaction of these proteins. In
present study, we aimed to analyze the biological function of the pSer68-PLM-
NCX1 interaction by developing anchoring disruptor peptides. We observed
that PLM co-fractionated and co-immunoprecipitated with NCX1 in rat left
ventricle (LV) and in co-transfected HEK293 cells. Strong binding of
pSer68-PLM to one of the previously reported NCX1-QKHPD regions was
demonstrated in pull-down and overlay assays. Single amino acid substitutions
of native NCX1 peptide sequence 1-KHPDKEIEQLIELANYQVLS-20 re-
vealed that single substitutions at position 1-11 (particularly with tryptophan
or tyrosine) increased binding affinity of the peptide to pSer68-PLM. Interest-
ingly, we found that double substitution at position 4 and 6 with tyrosine (D4Y
and E6Y) in the native peptide sequence enhanced the binding affinity to
pSer68-PLM 8-fold, compared to native sequence. The optimized peptide 1-
KHPYKYIEQLIELANYQVLS-20 was further tested in a series of electro-
physiological experiments using whole-cell voltage clamp technique, with
voltage-ramp protocol employed to elicit NCX current. Constitutively phos-
phorylated (S68D) PLM was observed to inhibit NCX1 current in both forward
and reverse mode. Inclusion of the disruptor peptide in the patch pipette
reversed S68D-PLM inhibition of NCX1, while NCX current was not altered
by a scrambled peptide control. Taken together these data strongly suggest
that PLM interacts directly with NCX1, and that when PLM is phosphorylated
at serine 68, the interaction inhibits NCX1 activity.
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Human beta-cell insulin secretion is dependent on Ca2þ entry through voltage-
dependent Ca2þ channels (VDCCs). Kþ channels modulate the beta-cell
membrane potential, which influences VDCC activity. The most abundant
Kþ channel of the human islet is the two-pore domain Kþ (K2P) channel
TALK-1; however, its function is unknown. We characterized TALK-1 cur-
rents in primary mouse beta-cells and find that K2P currents are significantly
reduced after genetic ablation of TALK-1. To identify mechanisms that regu-
late TALK-1 channel activity, we used a Tlþ-sensitive fluorescent screen to
assess if TALK-1 is regulated by kinases. Cells expressing TALK-1 channels
were monitored for changes in Tlþ flux in response to co-expression with a
constitutively active kinase (examining a total of 192 kinases), revealing 9 ki-
nases that modify Tlþ flux through TALK-1. Interestingly, three phosphatidy-
linositol phosphate kinases (PIKs) including PIK3CG, PI4K2B, and PIKFYVE,
increased TALK-1 channel activity. To determine if activation of TALK-1
channels by PIKs is due to build-up of PIPs, we depleted membrane PIP2
with a rapamycin-recruitable phosphatase and found that TALK-1 channel
activity was reduced. As charged residues of other Kþ channels mediate
PIP2 sensitivity, we assessed if PIP2 influences TALK-1 channel activity
through a charged residue enriched domain in the C-terminus. We found that
neutralization of these charged residues significantly reduced PIP2 activation
of TALK-1 channels. Importantly, PIP2 introduced via patch pipette into pri-
mary mouse beta-cells also significantly enhanced TALK-1 currents. As
glucose induces Ca2þ-dependent oscillations in beta-cell PIP2, we then as-
sessed how TALK-1 regulates islet Ca2þ dynamics. We find that Ca2þ oscilla-
tion frequency is significantly increased in islets lacking TALK-1, which
